-
Archives
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- February 2016
- January 2016
- October 2014
- September 2014
- January 2013
-
Meta
Category Archives: The Charlton Centre
Saphnelo for Lupus
Saphnelo (anifrolumab) is a one-of-a-kind therapy by AstraZeneca for the treatment of moderate to severe systemic lupus erythematosus (SLE). In December of 2023, Saphnelo was approved for coverage under the Ontario Exceptional Access Program (EAP). SLE is an autoimmune condition … Continue reading
Posted in The Charlton Centre
Leave a comment
A New Treatment Option for Alopecia Areata
On December 4, 2023, Health Canada approved Pfizer’s Litfulo (ritlecitinib). Litfulo is a once-daily oral capsule used for the treatment of patients over 12 years old with severe alopecia areata. Alopecia areata is an autoimmune condition, where the immune system produces … Continue reading
Posted in The Charlton Centre
Leave a comment
Infliximab Now Available As An Injection for Crohn’s and Ulcerative Colitis Patients
Infliximab is a protein-based medication referred to as a biologic that treats many immune-mediated conditions. The original manufacturer of this medication is Janssen, and they named it Remicade. In the last several years other manufacturers have produced infliximab as biosimilars. … Continue reading
Posted in The Charlton Centre
Leave a comment
A New Treatment For Ulcerative Colitis
On October 3rd, 2023, Health Canada approved Eli Lilly’s newest biologic for the treatment of moderate to severe active ulcerative colitis (UC) called Omvoh. With a limited number of therapies available for UC in Canada, the introduction of a new advanced … Continue reading
Posted in The Charlton Centre
Leave a comment
Show Love to your Heart
As February is heart month, today is an excellent occasion to really show why we love our hearts and how we can reduce our risk of cardiovascular disease. Many studies have shown that patients who have autoimmune conditions are at higher risk of developing heart-related problems such as … Continue reading
Posted in The Charlton Centre
Leave a comment
Charlton Infusion Clinic Expansion
To better serve our Hamilton and area patients, we have expanded and moved our Stoney Creek Clinic for infusions to 211 Pritchard Road unit # 4. With this expansion, we have additional space to offer our Hamilton patients while maintaining … Continue reading
Posted in The Charlton Centre
Leave a comment
Do you use the government’s Trillium program in addition to your drug plan?
We are very fortunate in the province of Ontario to have many options for supporting the cost of prescription medications. At Charlton Health we work with specialty medications that have a high cost. These medications are paid for through patient’s … Continue reading
Posted in The Charlton Centre
Leave a comment
Happy New Year from Charlton Health!
The team at Charlton Health is celebrating the New Year at our new location, 211 Pritchard Rd. Unit 4 in Hamilton. Our team is very excited with our new expanded space and patients who live locally have been very pleased … Continue reading
Posted in The Charlton Centre
Leave a comment
We’re Moving!
Charlton Health Pharmacy is excited to announce our move to a new expanded facility on the East Hamilton Mountain, as of December 18th. This location has lots of free parking! The pharmacy is on the main floor of the building. … Continue reading
Posted in The Charlton Centre
Leave a comment
Health Canada Approves Ustekinumab (Stelara) Biosimilar
Health Canada has approved Jamteki as the first biosimilar in Canada of ustekinumab for the treatment of psoriasis and psoriatic arthritis. We expect that it will eventually be approved for Crohn’s Disease and Ulcerative Colitis as the originator ustekinumab (Stelara) … Continue reading
Posted in The Charlton Centre
Leave a comment